Markets:

Overview

News

Currencies

International

Treasuries

Neuropace, Inc. - Common Stock (NQ:NPCE)

14.34 -0.15 (-1.04%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Neuropace, Inc. - Common Stock

< Previous 1 2 3 4 Next >

NeuroPace's Return On Capital Employed Overview ↗

May 18, 2023

Via Benzinga

Recap: NeuroPace Q1 Earnings ↗

May 04, 2023

Via Benzinga

Looking Into NeuroPace's Return On Capital Employed ↗

March 08, 2023

Via Benzinga

Dow Jumps Over 300 Points; S&P 500 Rises 1.5% ↗

March 03, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Friday. The Dow traded up 1.03% to 33,343.73 while the NASDAQ rose 1.92% to 11,682.86. The S&P...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 03, 2023

Via Benzinga

Nasdaq Up 150 Points; Crude Oil Rises 1% ↗

March 03, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Friday. The Dow traded up 0.59% to 33,197.08 while the NASDAQ rose 1.32% to 11,614.60. The S&P...

Via Benzinga

NeuroPace Earnings Preview ↗

March 01, 2023

Via Benzinga

NeuroPace: Q2 Earnings Insights ↗

August 11, 2022

NeuroPace (NASDAQ:NPCE) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For August 11, 2022 ↗

August 11, 2022

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

Via Benzinga

Expert Ratings For NeuroPace ↗

April 06, 2022

Analysts have provided the following ratings for NeuroPace (NASDAQ:NPCE) within the last quarter:

Via Benzinga

Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 03, 2023

Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023 ↗

February 22, 2023

Via Benzinga

Bear Of The Day: NeuroPace (NPCE) ↗

March 21, 2022

NeuroPace is a $200 million commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from epilepsy.

Via Talk Markets

Earnings Scheduled For March 10, 2022 ↗

March 10, 2022

Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 04, 2022

On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 13, 2023

Via Benzinga

Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 10, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 02, 2023

Via Benzinga

$10 Million Bet On Canoo? Check Out These 3 Stocks Under $3 Insiders Are Buying ↗

November 25, 2022

The Nasdaq Composite closed higher by more than 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 24, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

November 14, 2022

Monday saw 33 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 25, 2022

On Tuesday, 120 companies set new 52-week lows.

Via Benzinga

NeuroPace's Return On Capital Employed Insights ↗

September 07, 2022

NeuroPace (NASDAQ:NPCE) brought in sales totaling $10.20 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 10.72%, resulting in a loss of $12.69 million.

Via Benzinga

89 Biggest Movers From Friday ↗

June 21, 2022

Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

June 02, 2022

During the Thursday's session, 100 stocks hit new 52-week lows.

Via Benzinga

5 Analysts Have This to Say About NeuroPace ↗

May 13, 2022

Over the past 3 months, 5 analysts have published their opinion on NeuroPace (NASDAQ:NPCE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Recap: NeuroPace Q1 Earnings ↗

May 12, 2022

NeuroPace (NASDAQ:NPCE) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings NeuroPace missed estimated earnings...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022 ↗

April 06, 2022

Upgrades

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

February 07, 2022

On Monday, 71 stocks hit new 52-week lows. Noteable 52-Week Lows: 3M (NYSE:MMM) was the biggest company in terms of market cap to set a new 52-week low. OceanPal (...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Neuropace, Inc. - Common Stock (NQ:NPCE)

Headline News about Neuropace, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today